Read More

Elbit Systems Announced Earlier It Was Awarded $180M Contract From The Israeli MOD To Provide a New Mission Training Center For Its F-16 Fleet

Elbit Systems Ltd. (NASDAQ: ESLT) (TASE: ESLT) ("Elbit Systems" or the "Company") announced today that it was awarded a contract in an amount of approximately $180 million from the Israeli Ministry of Defense (IMoD) to provide, operate and maintain the new Mission Training Center (MTC) for the Israeli Air Force's (IAF) F-16 fl

ESLT

Read More

Day One Announced Sunday Topline Data from Pivotal Phase 2 FIREFLY-1 Trial Demonstrating Meaningful Responses with Tovorafenib (DAY101) in Recurrent or Progressive Pediatric Low-Grade Glioma

Day One Biopharmaceuticals (NASDAQ: DAWN), a clinical-stage biopharmaceutical company dedicated to developing and commercializing targeted therapies for people of all ages with life-threatening diseases, today announced positive topline results from the ongoing, open-label, pivotal Phase 2 FIREFLY-1 trial evaluating the invest

DAWN